Aripiprazole is an atypical antipsychotic drug that is available as ABILIFY® indicated for schizophrenia, manic and mixed episodes of Bipolar I, adjunctive treatment for major depressive disorder and treatment of Tourette’s disorder.
VERSACLOZ is indicated for the treatment of severely ill patients with schizophrenia who fail to respond adequately to standard antipsychotic treatment.
CLOZARIL® (clozapine), an atypical antipsychotic drug, is a tricyclic dibenzodiazepine derivative. CLOZARIL is indicated for the treatment of severely ill patients with schizophrenia who fail to respond adequately to standard antipsychotic treatment
It is also used for the management of schizoaffective disorder, delusional disorders, ballism, and Tourette syndrome (a drug of choice) and occasionally as adjunctive therapy in mental retardation and the chorea associated with Huntington’s disease
